Opthea Limited (OPT)
NASDAQ: OPT · Real-Time Price · USD
3.410
0.00 (0.00%)
At close: Aug 20, 2025
Opthea Market Cap
Opthea has a market cap or net worth of $466.57 million as of August 21, 2025. Its market cap has increased by 55.77% in one year.
Market Cap
466.57M
Enterprise Value
559.27M
1-Year Change
55.77%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since the IPO on May 10, 2007, Opthea's market cap has increased from $49.90M to $466.57M, an increase of 835.07%. That is a compound annual growth rate of 13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 14, 2025 | 466.57M | -24.40% |
| Dec 31, 2024 | 617.19M | 139.65% |
| Dec 29, 2023 | 257.53M | -11.31% |
| Dec 30, 2022 | 290.38M | -12.38% |
| Dec 31, 2021 | 331.39M | -33.74% |
| Dec 31, 2020 | 500.17M | -11.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 626.66B |
| Johnson & Johnson | 424.47B |
| AbbVie | 364.92B |
| UnitedHealth Group | 279.39B |
| AstraZeneca | 246.07B |
| Novo Nordisk | 241.43B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 226.73B |